Product NDC: | 52544-494 |
Proprietary Name: | LOXITANE |
Non Proprietary Name: | loxapine succinate |
Active Ingredient(s): | 5 mg/1 & nbsp; loxapine succinate |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52544-494 |
Labeler Name: | Watson Pharma, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA072204 |
Marketing Category: | ANDA |
Start Marketing Date: | 19880615 |
Package NDC: | 52544-494-10 |
Package Description: | 1000 CAPSULE in 1 BOTTLE, PLASTIC (52544-494-10) |
NDC Code | 52544-494-10 |
Proprietary Name | LOXITANE |
Package Description | 1000 CAPSULE in 1 BOTTLE, PLASTIC (52544-494-10) |
Product NDC | 52544-494 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | loxapine succinate |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 19880615 |
Marketing Category Name | ANDA |
Labeler Name | Watson Pharma, Inc. |
Substance Name | LOXAPINE SUCCINATE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes |